Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Remplir™ Nerve Sparing Prostate Cancer Surgery Commercial Opportunity Gathers Momentum with ~100 Surgeries Now Performed with Multiple Surgeons Nationwide 2025-11-20 13:52
Globally Significant Opportunity Emerges as Remplir™ is used in Nerve-Sparing Prostate Cancer Surgery 2025-09-16 12:13
Remplir™ Study Delivers Compelling 81% Success Rate 2025-09-08 17:32
1